nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—Salicylic acid—Niacin—atherosclerosis	0.389	1	CrCrCtD
Mefenamic acid—PTGS2—atherosclerosis	0.179	1	CbGaD
Mefenamic acid—CYP2C8—Simvastatin—atherosclerosis	0.0358	0.173	CbGbCtD
Mefenamic acid—CYP2C8—Lovastatin—atherosclerosis	0.035	0.17	CbGbCtD
Mefenamic acid—CYP2C8—Pravastatin—atherosclerosis	0.035	0.17	CbGbCtD
Mefenamic acid—CYP2C9—Rosuvastatin—atherosclerosis	0.0268	0.13	CbGbCtD
Mefenamic acid—CYP2C9—Simvastatin—atherosclerosis	0.0249	0.121	CbGbCtD
Mefenamic acid—CYP2C9—Lovastatin—atherosclerosis	0.0244	0.118	CbGbCtD
Mefenamic acid—CYP2C9—Pravastatin—atherosclerosis	0.0244	0.118	CbGbCtD
Mefenamic acid—AKR1C2—liver—atherosclerosis	0.00121	0.119	CbGeAlD
Mefenamic acid—PTGS2—leg—atherosclerosis	0.00108	0.107	CbGeAlD
Mefenamic acid—PTGS2—hindlimb—atherosclerosis	0.000968	0.0954	CbGeAlD
Mefenamic acid—Niflumic Acid—PLA2G1B—atherosclerosis	0.00091	0.194	CrCbGaD
Mefenamic acid—PTGS2—appendage—atherosclerosis	0.000831	0.0819	CbGeAlD
Mefenamic acid—Diclofenac—PLA2G2A—atherosclerosis	0.000658	0.141	CrCbGaD
Mefenamic acid—PTGS1—artery—atherosclerosis	0.000621	0.0612	CbGeAlD
Mefenamic acid—PTGS2—artery—atherosclerosis	0.000594	0.0585	CbGeAlD
Mefenamic acid—AKR1C3—adipose tissue—atherosclerosis	0.000538	0.053	CbGeAlD
Mefenamic acid—PTGS1—endothelium—atherosclerosis	0.000525	0.0517	CbGeAlD
Mefenamic acid—PTGS2—endothelium—atherosclerosis	0.000501	0.0494	CbGeAlD
Mefenamic acid—PTGS1—blood vessel—atherosclerosis	0.000484	0.0477	CbGeAlD
Mefenamic acid—PTGS2—blood vessel—atherosclerosis	0.000462	0.0456	CbGeAlD
Mefenamic acid—Acetylsalicylic acid—EDNRA—atherosclerosis	0.000436	0.0931	CrCbGaD
Mefenamic acid—Meclofenamic acid—ALOX5—atherosclerosis	0.000422	0.0902	CrCbGaD
Mefenamic acid—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000415	0.00414	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000414	0.00413	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000401	0.004	CcSEcCtD
Mefenamic acid—Jaundice—Ezetimibe—atherosclerosis	0.000401	0.004	CcSEcCtD
Mefenamic acid—Arrhythmia—Rosuvastatin—atherosclerosis	0.000396	0.00396	CcSEcCtD
Mefenamic acid—Eosinophilia—Pravastatin—atherosclerosis	0.000393	0.00393	CcSEcCtD
Mefenamic acid—Pancreatitis—Pravastatin—atherosclerosis	0.00039	0.00389	CcSEcCtD
Mefenamic acid—Mental disorder—Rosuvastatin—atherosclerosis	0.000389	0.00388	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000389	0.00388	CcSEcCtD
Mefenamic acid—Jaundice—Simvastatin—atherosclerosis	0.000382	0.00381	CcSEcCtD
Mefenamic acid—Flatulence—Rosuvastatin—atherosclerosis	0.000381	0.0038	CcSEcCtD
Mefenamic acid—AKR1C3—liver—atherosclerosis	0.000377	0.0372	CbGeAlD
Mefenamic acid—Hepatitis—Lovastatin—atherosclerosis	0.000376	0.00375	CcSEcCtD
Mefenamic acid—Dysuria—Pravastatin—atherosclerosis	0.000372	0.00371	CcSEcCtD
Mefenamic acid—Hepatitis—Ezetimibe—atherosclerosis	0.000369	0.00368	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000363	0.00362	CcSEcCtD
Mefenamic acid—Erythema multiforme—Lovastatin—atherosclerosis	0.000356	0.00355	CcSEcCtD
Mefenamic acid—Angioedema—Rosuvastatin—atherosclerosis	0.000353	0.00352	CcSEcCtD
Mefenamic acid—Hepatitis—Simvastatin—atherosclerosis	0.000352	0.00351	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000351	0.00351	CcSEcCtD
Mefenamic acid—Stomatitis—Niacin—atherosclerosis	0.000351	0.0035	CcSEcCtD
Mefenamic acid—Jaundice—Niacin—atherosclerosis	0.000351	0.0035	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000349	0.00349	CcSEcCtD
Mefenamic acid—Erythema multiforme—Ezetimibe—atherosclerosis	0.000349	0.00348	CcSEcCtD
Mefenamic acid—Myocardial infarction—Pravastatin—atherosclerosis	0.000347	0.00347	CcSEcCtD
Mefenamic acid—Jaundice—Pravastatin—atherosclerosis	0.000345	0.00345	CcSEcCtD
Mefenamic acid—Erythema multiforme—Simvastatin—atherosclerosis	0.000333	0.00332	CcSEcCtD
Mefenamic acid—Alopecia—Lovastatin—atherosclerosis	0.000332	0.00332	CcSEcCtD
Mefenamic acid—Alopecia—Ezetimibe—atherosclerosis	0.000326	0.00325	CcSEcCtD
Mefenamic acid—Haemoglobin—Niacin—atherosclerosis	0.000325	0.00324	CcSEcCtD
Mefenamic acid—Mental disorder—Ezetimibe—atherosclerosis	0.000323	0.00323	CcSEcCtD
Mefenamic acid—Haemorrhage—Niacin—atherosclerosis	0.000323	0.00322	CcSEcCtD
Mefenamic acid—Hepatitis—Niacin—atherosclerosis	0.000323	0.00322	CcSEcCtD
Mefenamic acid—Flatulence—Lovastatin—atherosclerosis	0.000323	0.00322	CcSEcCtD
Mefenamic acid—Hepatitis—Pravastatin—atherosclerosis	0.000318	0.00317	CcSEcCtD
Mefenamic acid—Confusional state—Rosuvastatin—atherosclerosis	0.000318	0.00317	CcSEcCtD
Mefenamic acid—Flatulence—Ezetimibe—atherosclerosis	0.000316	0.00316	CcSEcCtD
Mefenamic acid—Infection—Rosuvastatin—atherosclerosis	0.000313	0.00313	CcSEcCtD
Mefenamic acid—Alopecia—Simvastatin—atherosclerosis	0.000311	0.0031	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000309	0.00308	CcSEcCtD
Mefenamic acid—Vision blurred—Lovastatin—atherosclerosis	0.000309	0.00308	CcSEcCtD
Mefenamic acid—Mental disorder—Simvastatin—atherosclerosis	0.000308	0.00308	CcSEcCtD
Mefenamic acid—Tremor—Lovastatin—atherosclerosis	0.000307	0.00306	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Lovastatin—atherosclerosis	0.000304	0.00303	CcSEcCtD
Mefenamic acid—Flatulence—Simvastatin—atherosclerosis	0.000302	0.00301	CcSEcCtD
Mefenamic acid—Tinnitus—Niacin—atherosclerosis	0.000301	0.00301	CcSEcCtD
Mefenamic acid—Erythema multiforme—Pravastatin—atherosclerosis	0.000301	0.003	CcSEcCtD
Mefenamic acid—Angioedema—Lovastatin—atherosclerosis	0.000299	0.00299	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000298	0.00297	CcSEcCtD
Mefenamic acid—Anaemia—Ezetimibe—atherosclerosis	0.000297	0.00296	CcSEcCtD
Mefenamic acid—Tinnitus—Pravastatin—atherosclerosis	0.000297	0.00296	CcSEcCtD
Mefenamic acid—Malaise—Lovastatin—atherosclerosis	0.000295	0.00295	CcSEcCtD
Mefenamic acid—Vertigo—Lovastatin—atherosclerosis	0.000294	0.00294	CcSEcCtD
Mefenamic acid—Angioedema—Ezetimibe—atherosclerosis	0.000293	0.00293	CcSEcCtD
Mefenamic acid—Leukopenia—Lovastatin—atherosclerosis	0.000293	0.00292	CcSEcCtD
Mefenamic acid—Malaise—Ezetimibe—atherosclerosis	0.00029	0.00289	CcSEcCtD
Mefenamic acid—Vision blurred—Simvastatin—atherosclerosis	0.000289	0.00288	CcSEcCtD
Mefenamic acid—Arrhythmia—Niacin—atherosclerosis	0.000289	0.00288	CcSEcCtD
Mefenamic acid—Tremor—Simvastatin—atherosclerosis	0.000287	0.00286	CcSEcCtD
Mefenamic acid—Alopecia—Niacin—atherosclerosis	0.000285	0.00285	CcSEcCtD
Mefenamic acid—Insomnia—Rosuvastatin—atherosclerosis	0.000285	0.00285	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Simvastatin—atherosclerosis	0.000284	0.00284	CcSEcCtD
Mefenamic acid—Arrhythmia—Pravastatin—atherosclerosis	0.000284	0.00284	CcSEcCtD
Mefenamic acid—Palpitations—Ezetimibe—atherosclerosis	0.000284	0.00283	CcSEcCtD
Mefenamic acid—Paraesthesia—Rosuvastatin—atherosclerosis	0.000283	0.00283	CcSEcCtD
Mefenamic acid—Anaemia—Simvastatin—atherosclerosis	0.000283	0.00282	CcSEcCtD
Mefenamic acid—Alopecia—Pravastatin—atherosclerosis	0.000281	0.0028	CcSEcCtD
Mefenamic acid—Angioedema—Simvastatin—atherosclerosis	0.00028	0.00279	CcSEcCtD
Mefenamic acid—Anxiety—Lovastatin—atherosclerosis	0.000278	0.00277	CcSEcCtD
Mefenamic acid—Dyspepsia—Rosuvastatin—atherosclerosis	0.000278	0.00277	CcSEcCtD
Mefenamic acid—Hypertension—Ezetimibe—atherosclerosis	0.000277	0.00277	CcSEcCtD
Mefenamic acid—Flatulence—Niacin—atherosclerosis	0.000277	0.00277	CcSEcCtD
Mefenamic acid—Malaise—Simvastatin—atherosclerosis	0.000276	0.00276	CcSEcCtD
Mefenamic acid—Tension—Niacin—atherosclerosis	0.000276	0.00275	CcSEcCtD
Mefenamic acid—Discomfort—Lovastatin—atherosclerosis	0.000275	0.00275	CcSEcCtD
Mefenamic acid—Vertigo—Simvastatin—atherosclerosis	0.000275	0.00275	CcSEcCtD
Mefenamic acid—Leukopenia—Simvastatin—atherosclerosis	0.000274	0.00274	CcSEcCtD
Mefenamic acid—Nervousness—Niacin—atherosclerosis	0.000273	0.00273	CcSEcCtD
Mefenamic acid—Flatulence—Pravastatin—atherosclerosis	0.000273	0.00272	CcSEcCtD
Mefenamic acid—Dry mouth—Lovastatin—atherosclerosis	0.000273	0.00272	CcSEcCtD
Mefenamic acid—Tension—Pravastatin—atherosclerosis	0.000272	0.00271	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000272	0.00271	CcSEcCtD
Mefenamic acid—Discomfort—Ezetimibe—atherosclerosis	0.00027	0.0027	CcSEcCtD
Mefenamic acid—Constipation—Rosuvastatin—atherosclerosis	0.00027	0.00269	CcSEcCtD
Mefenamic acid—Confusional state—Lovastatin—atherosclerosis	0.000269	0.00269	CcSEcCtD
Mefenamic acid—Nervousness—Pravastatin—atherosclerosis	0.000269	0.00268	CcSEcCtD
Mefenamic acid—Dry mouth—Ezetimibe—atherosclerosis	0.000267	0.00267	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Lovastatin—atherosclerosis	0.000267	0.00267	CcSEcCtD
Mefenamic acid—Infection—Lovastatin—atherosclerosis	0.000265	0.00265	CcSEcCtD
Mefenamic acid—Vision blurred—Niacin—atherosclerosis	0.000265	0.00264	CcSEcCtD
Mefenamic acid—Confusional state—Ezetimibe—atherosclerosis	0.000264	0.00264	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000262	0.00262	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Lovastatin—atherosclerosis	0.000262	0.00261	CcSEcCtD
Mefenamic acid—Vision blurred—Pravastatin—atherosclerosis	0.000261	0.0026	CcSEcCtD
Mefenamic acid—Infection—Ezetimibe—atherosclerosis	0.00026	0.0026	CcSEcCtD
Mefenamic acid—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00026	0.00259	CcSEcCtD
Mefenamic acid—Anxiety—Simvastatin—atherosclerosis	0.00026	0.00259	CcSEcCtD
Mefenamic acid—Tremor—Pravastatin—atherosclerosis	0.000259	0.00259	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000258	0.00257	CcSEcCtD
Mefenamic acid—Discomfort—Simvastatin—atherosclerosis	0.000258	0.00257	CcSEcCtD
Mefenamic acid—Angioedema—Niacin—atherosclerosis	0.000257	0.00256	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Pravastatin—atherosclerosis	0.000257	0.00256	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000257	0.00256	CcSEcCtD
Mefenamic acid—Anaemia—Pravastatin—atherosclerosis	0.000256	0.00255	CcSEcCtD
Mefenamic acid—Anorexia—Lovastatin—atherosclerosis	0.000255	0.00254	CcSEcCtD
Mefenamic acid—Skin disorder—Ezetimibe—atherosclerosis	0.000255	0.00254	CcSEcCtD
Mefenamic acid—Angioedema—Pravastatin—atherosclerosis	0.000253	0.00252	CcSEcCtD
Mefenamic acid—Vertigo—Niacin—atherosclerosis	0.000253	0.00252	CcSEcCtD
Mefenamic acid—Syncope—Niacin—atherosclerosis	0.000252	0.00252	CcSEcCtD
Mefenamic acid—Confusional state—Simvastatin—atherosclerosis	0.000252	0.00251	CcSEcCtD
Mefenamic acid—Leukopenia—Niacin—atherosclerosis	0.000252	0.00251	CcSEcCtD
Mefenamic acid—Urticaria—Rosuvastatin—atherosclerosis	0.00025	0.0025	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Simvastatin—atherosclerosis	0.00025	0.00249	CcSEcCtD
Mefenamic acid—Oedema—Simvastatin—atherosclerosis	0.00025	0.00249	CcSEcCtD
Mefenamic acid—Malaise—Pravastatin—atherosclerosis	0.00025	0.00249	CcSEcCtD
Mefenamic acid—Abdominal pain—Rosuvastatin—atherosclerosis	0.000249	0.00249	CcSEcCtD
Mefenamic acid—Vertigo—Pravastatin—atherosclerosis	0.000249	0.00248	CcSEcCtD
Mefenamic acid—Palpitations—Niacin—atherosclerosis	0.000248	0.00248	CcSEcCtD
Mefenamic acid—Infection—Simvastatin—atherosclerosis	0.000248	0.00248	CcSEcCtD
Mefenamic acid—PTGS1—connective tissue—atherosclerosis	0.000248	0.0244	CbGeAlD
Mefenamic acid—Leukopenia—Pravastatin—atherosclerosis	0.000248	0.00247	CcSEcCtD
Mefenamic acid—Loss of consciousness—Niacin—atherosclerosis	0.000247	0.00247	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Simvastatin—atherosclerosis	0.000245	0.00244	CcSEcCtD
Mefenamic acid—Insomnia—Lovastatin—atherosclerosis	0.000242	0.00241	CcSEcCtD
Mefenamic acid—Paraesthesia—Lovastatin—atherosclerosis	0.00024	0.00239	CcSEcCtD
Mefenamic acid—Hypertension—Pravastatin—atherosclerosis	0.000239	0.00239	CcSEcCtD
Mefenamic acid—Anorexia—Simvastatin—atherosclerosis	0.000238	0.00238	CcSEcCtD
Mefenamic acid—Dyspnoea—Lovastatin—atherosclerosis	0.000238	0.00238	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000238	0.00237	CcSEcCtD
Mefenamic acid—PTGS2—connective tissue—atherosclerosis	0.000237	0.0234	CbGeAlD
Mefenamic acid—Insomnia—Ezetimibe—atherosclerosis	0.000237	0.00237	CcSEcCtD
Mefenamic acid—CYP2C9—cardiovascular system—atherosclerosis	0.000236	0.0233	CbGeAlD
Mefenamic acid—Diclofenac—ALOX5—atherosclerosis	0.000236	0.0504	CrCbGaD
Mefenamic acid—Paraesthesia—Ezetimibe—atherosclerosis	0.000235	0.00235	CcSEcCtD
Mefenamic acid—Dyspepsia—Lovastatin—atherosclerosis	0.000235	0.00235	CcSEcCtD
Mefenamic acid—Anxiety—Pravastatin—atherosclerosis	0.000235	0.00234	CcSEcCtD
Mefenamic acid—Dry mouth—Niacin—atherosclerosis	0.000234	0.00234	CcSEcCtD
Mefenamic acid—Dyspnoea—Ezetimibe—atherosclerosis	0.000234	0.00233	CcSEcCtD
Mefenamic acid—Discomfort—Pravastatin—atherosclerosis	0.000233	0.00232	CcSEcCtD
Mefenamic acid—Decreased appetite—Lovastatin—atherosclerosis	0.000232	0.00232	CcSEcCtD
Mefenamic acid—Dyspepsia—Ezetimibe—atherosclerosis	0.000231	0.0023	CcSEcCtD
Mefenamic acid—Oedema—Niacin—atherosclerosis	0.000229	0.00229	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Niacin—atherosclerosis	0.000229	0.00229	CcSEcCtD
Mefenamic acid—Constipation—Lovastatin—atherosclerosis	0.000228	0.00228	CcSEcCtD
Mefenamic acid—Confusional state—Pravastatin—atherosclerosis	0.000228	0.00227	CcSEcCtD
Mefenamic acid—Decreased appetite—Ezetimibe—atherosclerosis	0.000228	0.00227	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000226	0.00226	CcSEcCtD
Mefenamic acid—Asthenia—Rosuvastatin—atherosclerosis	0.000226	0.00226	CcSEcCtD
Mefenamic acid—Insomnia—Simvastatin—atherosclerosis	0.000226	0.00226	CcSEcCtD
Mefenamic acid—Oedema—Pravastatin—atherosclerosis	0.000226	0.00225	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Pravastatin—atherosclerosis	0.000226	0.00225	CcSEcCtD
Mefenamic acid—Shock—Niacin—atherosclerosis	0.000226	0.00225	CcSEcCtD
Mefenamic acid—Infection—Pravastatin—atherosclerosis	0.000224	0.00224	CcSEcCtD
Mefenamic acid—Paraesthesia—Simvastatin—atherosclerosis	0.000224	0.00224	CcSEcCtD
Mefenamic acid—Constipation—Ezetimibe—atherosclerosis	0.000224	0.00224	CcSEcCtD
Mefenamic acid—Tachycardia—Niacin—atherosclerosis	0.000224	0.00224	CcSEcCtD
Mefenamic acid—Pruritus—Rosuvastatin—atherosclerosis	0.000223	0.00223	CcSEcCtD
Mefenamic acid—Skin disorder—Niacin—atherosclerosis	0.000223	0.00222	CcSEcCtD
Mefenamic acid—Dyspnoea—Simvastatin—atherosclerosis	0.000223	0.00222	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Pravastatin—atherosclerosis	0.000221	0.00221	CcSEcCtD
Mefenamic acid—Feeling abnormal—Lovastatin—atherosclerosis	0.00022	0.0022	CcSEcCtD
Mefenamic acid—Dyspepsia—Simvastatin—atherosclerosis	0.00022	0.0022	CcSEcCtD
Mefenamic acid—Anorexia—Niacin—atherosclerosis	0.000219	0.00218	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000218	0.00218	CcSEcCtD
Mefenamic acid—Decreased appetite—Simvastatin—atherosclerosis	0.000217	0.00217	CcSEcCtD
Mefenamic acid—Feeling abnormal—Ezetimibe—atherosclerosis	0.000216	0.00216	CcSEcCtD
Mefenamic acid—PTGS1—cardiovascular system—atherosclerosis	0.000216	0.0213	CbGeAlD
Mefenamic acid—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000216	0.00215	CcSEcCtD
Mefenamic acid—Diarrhoea—Rosuvastatin—atherosclerosis	0.000216	0.00215	CcSEcCtD
Mefenamic acid—Anorexia—Pravastatin—atherosclerosis	0.000215	0.00215	CcSEcCtD
Mefenamic acid—Hypotension—Niacin—atherosclerosis	0.000214	0.00214	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000214	0.00214	CcSEcCtD
Mefenamic acid—Constipation—Simvastatin—atherosclerosis	0.000214	0.00213	CcSEcCtD
Mefenamic acid—Urticaria—Lovastatin—atherosclerosis	0.000212	0.00212	CcSEcCtD
Mefenamic acid—Abdominal pain—Lovastatin—atherosclerosis	0.000211	0.00211	CcSEcCtD
Mefenamic acid—Body temperature increased—Lovastatin—atherosclerosis	0.000211	0.00211	CcSEcCtD
Mefenamic acid—Dizziness—Rosuvastatin—atherosclerosis	0.000208	0.00208	CcSEcCtD
Mefenamic acid—Urticaria—Ezetimibe—atherosclerosis	0.000208	0.00208	CcSEcCtD
Mefenamic acid—Insomnia—Niacin—atherosclerosis	0.000208	0.00207	CcSEcCtD
Mefenamic acid—Abdominal pain—Ezetimibe—atherosclerosis	0.000207	0.00207	CcSEcCtD
Mefenamic acid—Body temperature increased—Ezetimibe—atherosclerosis	0.000207	0.00207	CcSEcCtD
Mefenamic acid—PTGS2—cardiovascular system—atherosclerosis	0.000206	0.0203	CbGeAlD
Mefenamic acid—Paraesthesia—Niacin—atherosclerosis	0.000206	0.00206	CcSEcCtD
Mefenamic acid—Feeling abnormal—Simvastatin—atherosclerosis	0.000206	0.00206	CcSEcCtD
Mefenamic acid—Dyspnoea—Niacin—atherosclerosis	0.000205	0.00204	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000204	0.00204	CcSEcCtD
Mefenamic acid—Insomnia—Pravastatin—atherosclerosis	0.000204	0.00204	CcSEcCtD
Mefenamic acid—Somnolence—Niacin—atherosclerosis	0.000204	0.00204	CcSEcCtD
Mefenamic acid—Floctafenine—PTGS2—atherosclerosis	0.000203	0.0434	CrCbGaD
Mefenamic acid—Paraesthesia—Pravastatin—atherosclerosis	0.000203	0.00202	CcSEcCtD
Mefenamic acid—Dyspepsia—Niacin—atherosclerosis	0.000202	0.00202	CcSEcCtD
Mefenamic acid—Dyspnoea—Pravastatin—atherosclerosis	0.000201	0.00201	CcSEcCtD
Mefenamic acid—Decreased appetite—Niacin—atherosclerosis	0.000199	0.00199	CcSEcCtD
Mefenamic acid—Dyspepsia—Pravastatin—atherosclerosis	0.000199	0.00198	CcSEcCtD
Mefenamic acid—Rash—Rosuvastatin—atherosclerosis	0.000199	0.00198	CcSEcCtD
Mefenamic acid—Dermatitis—Rosuvastatin—atherosclerosis	0.000199	0.00198	CcSEcCtD
Mefenamic acid—Urticaria—Simvastatin—atherosclerosis	0.000199	0.00198	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Niacin—atherosclerosis	0.000198	0.00198	CcSEcCtD
Mefenamic acid—Abdominal pain—Simvastatin—atherosclerosis	0.000198	0.00197	CcSEcCtD
Mefenamic acid—Body temperature increased—Simvastatin—atherosclerosis	0.000198	0.00197	CcSEcCtD
Mefenamic acid—Headache—Rosuvastatin—atherosclerosis	0.000198	0.00197	CcSEcCtD
Mefenamic acid—Decreased appetite—Pravastatin—atherosclerosis	0.000196	0.00196	CcSEcCtD
Mefenamic acid—Diclofenac—CXCL8—atherosclerosis	0.000195	0.0417	CrCbGaD
Mefenamic acid—Constipation—Pravastatin—atherosclerosis	0.000193	0.00193	CcSEcCtD
Mefenamic acid—Asthenia—Lovastatin—atherosclerosis	0.000192	0.00191	CcSEcCtD
Mefenamic acid—PTGS1—adipose tissue—atherosclerosis	0.00019	0.0188	CbGeAlD
Mefenamic acid—Pruritus—Lovastatin—atherosclerosis	0.000189	0.00189	CcSEcCtD
Mefenamic acid—Asthenia—Ezetimibe—atherosclerosis	0.000188	0.00188	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Niacin—atherosclerosis	0.000188	0.00187	CcSEcCtD
Mefenamic acid—Nausea—Rosuvastatin—atherosclerosis	0.000187	0.00187	CcSEcCtD
Mefenamic acid—Feeling abnormal—Pravastatin—atherosclerosis	0.000186	0.00186	CcSEcCtD
Mefenamic acid—Pruritus—Ezetimibe—atherosclerosis	0.000185	0.00185	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000185	0.00184	CcSEcCtD
Mefenamic acid—Diarrhoea—Lovastatin—atherosclerosis	0.000183	0.00182	CcSEcCtD
Mefenamic acid—Urticaria—Niacin—atherosclerosis	0.000182	0.00182	CcSEcCtD
Mefenamic acid—PTGS2—adipose tissue—atherosclerosis	0.000182	0.0179	CbGeAlD
Mefenamic acid—Abdominal pain—Niacin—atherosclerosis	0.000181	0.00181	CcSEcCtD
Mefenamic acid—Body temperature increased—Niacin—atherosclerosis	0.000181	0.00181	CcSEcCtD
Mefenamic acid—Urticaria—Pravastatin—atherosclerosis	0.00018	0.00179	CcSEcCtD
Mefenamic acid—Asthenia—Simvastatin—atherosclerosis	0.000179	0.00179	CcSEcCtD
Mefenamic acid—Diarrhoea—Ezetimibe—atherosclerosis	0.000179	0.00179	CcSEcCtD
Mefenamic acid—Abdominal pain—Pravastatin—atherosclerosis	0.000179	0.00178	CcSEcCtD
Mefenamic acid—Body temperature increased—Pravastatin—atherosclerosis	0.000179	0.00178	CcSEcCtD
Mefenamic acid—Pruritus—Simvastatin—atherosclerosis	0.000177	0.00176	CcSEcCtD
Mefenamic acid—Dizziness—Lovastatin—atherosclerosis	0.000177	0.00176	CcSEcCtD
Mefenamic acid—Dizziness—Ezetimibe—atherosclerosis	0.000173	0.00173	CcSEcCtD
Mefenamic acid—Ketoprofen—CXCL8—atherosclerosis	0.000173	0.037	CrCbGaD
Mefenamic acid—Diarrhoea—Simvastatin—atherosclerosis	0.000171	0.00171	CcSEcCtD
Mefenamic acid—Vomiting—Lovastatin—atherosclerosis	0.00017	0.0017	CcSEcCtD
Mefenamic acid—Rash—Lovastatin—atherosclerosis	0.000168	0.00168	CcSEcCtD
Mefenamic acid—Dermatitis—Lovastatin—atherosclerosis	0.000168	0.00168	CcSEcCtD
Mefenamic acid—Headache—Lovastatin—atherosclerosis	0.000167	0.00167	CcSEcCtD
Mefenamic acid—Vomiting—Ezetimibe—atherosclerosis	0.000167	0.00166	CcSEcCtD
Mefenamic acid—Dizziness—Simvastatin—atherosclerosis	0.000165	0.00165	CcSEcCtD
Mefenamic acid—Rash—Ezetimibe—atherosclerosis	0.000165	0.00165	CcSEcCtD
Mefenamic acid—Dermatitis—Ezetimibe—atherosclerosis	0.000165	0.00165	CcSEcCtD
Mefenamic acid—Asthenia—Niacin—atherosclerosis	0.000165	0.00164	CcSEcCtD
Mefenamic acid—CYP2C8—liver—atherosclerosis	0.000165	0.0162	CbGeAlD
Mefenamic acid—Headache—Ezetimibe—atherosclerosis	0.000164	0.00164	CcSEcCtD
Mefenamic acid—Pruritus—Niacin—atherosclerosis	0.000162	0.00162	CcSEcCtD
Mefenamic acid—Asthenia—Pravastatin—atherosclerosis	0.000162	0.00162	CcSEcCtD
Mefenamic acid—Pruritus—Pravastatin—atherosclerosis	0.00016	0.0016	CcSEcCtD
Mefenamic acid—Vomiting—Simvastatin—atherosclerosis	0.000159	0.00159	CcSEcCtD
Mefenamic acid—Nausea—Lovastatin—atherosclerosis	0.000159	0.00158	CcSEcCtD
Mefenamic acid—Rash—Simvastatin—atherosclerosis	0.000158	0.00157	CcSEcCtD
Mefenamic acid—Dermatitis—Simvastatin—atherosclerosis	0.000157	0.00157	CcSEcCtD
Mefenamic acid—Diarrhoea—Niacin—atherosclerosis	0.000157	0.00157	CcSEcCtD
Mefenamic acid—Headache—Simvastatin—atherosclerosis	0.000157	0.00156	CcSEcCtD
Mefenamic acid—Nausea—Ezetimibe—atherosclerosis	0.000156	0.00155	CcSEcCtD
Mefenamic acid—Diarrhoea—Pravastatin—atherosclerosis	0.000155	0.00154	CcSEcCtD
Mefenamic acid—Dizziness—Niacin—atherosclerosis	0.000152	0.00151	CcSEcCtD
Mefenamic acid—Dizziness—Pravastatin—atherosclerosis	0.000149	0.00149	CcSEcCtD
Mefenamic acid—Nausea—Simvastatin—atherosclerosis	0.000148	0.00148	CcSEcCtD
Mefenamic acid—CYP2C9—liver—atherosclerosis	0.000146	0.0144	CbGeAlD
Mefenamic acid—Vomiting—Niacin—atherosclerosis	0.000146	0.00146	CcSEcCtD
Mefenamic acid—Rash—Niacin—atherosclerosis	0.000145	0.00144	CcSEcCtD
Mefenamic acid—Dermatitis—Niacin—atherosclerosis	0.000145	0.00144	CcSEcCtD
Mefenamic acid—Headache—Niacin—atherosclerosis	0.000144	0.00143	CcSEcCtD
Mefenamic acid—Vomiting—Pravastatin—atherosclerosis	0.000144	0.00143	CcSEcCtD
Mefenamic acid—Rash—Pravastatin—atherosclerosis	0.000142	0.00142	CcSEcCtD
Mefenamic acid—Dermatitis—Pravastatin—atherosclerosis	0.000142	0.00142	CcSEcCtD
Mefenamic acid—Headache—Pravastatin—atherosclerosis	0.000142	0.00141	CcSEcCtD
Mefenamic acid—Nausea—Niacin—atherosclerosis	0.000136	0.00136	CcSEcCtD
Mefenamic acid—Nausea—Pravastatin—atherosclerosis	0.000134	0.00134	CcSEcCtD
Mefenamic acid—Tiaprofenic acid—PTGS2—atherosclerosis	0.000131	0.028	CrCbGaD
Mefenamic acid—Lumiracoxib—PTGS2—atherosclerosis	0.000131	0.028	CrCbGaD
Mefenamic acid—PTGS2—liver—atherosclerosis	0.000128	0.0126	CbGeAlD
Mefenamic acid—Nepafenac—PTGS2—atherosclerosis	0.000125	0.0266	CrCbGaD
Mefenamic acid—Niflumic Acid—PTGS2—atherosclerosis	0.000117	0.0249	CrCbGaD
Mefenamic acid—Salsalate—PTGS2—atherosclerosis	0.000103	0.0221	CrCbGaD
Mefenamic acid—Meclofenamic acid—PTGS2—atherosclerosis	0.000102	0.0218	CrCbGaD
Mefenamic acid—Fenoprofen—PTGS2—atherosclerosis	8.55e-05	0.0183	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—PTGS2—atherosclerosis	7.73e-05	0.0165	CrCbGaD
Mefenamic acid—Fenoprofen—ALB—atherosclerosis	7.62e-05	0.0163	CrCbGaD
Mefenamic acid—Acetylsalicylic acid—ALB—atherosclerosis	6.89e-05	0.0147	CrCbGaD
Mefenamic acid—Salicylic acid—PTGS2—atherosclerosis	6.37e-05	0.0136	CrCbGaD
Mefenamic acid—Diclofenac—PTGS2—atherosclerosis	5.7e-05	0.0122	CrCbGaD
Mefenamic acid—Salicylic acid—ALB—atherosclerosis	5.67e-05	0.0121	CrCbGaD
Mefenamic acid—Flurbiprofen—PTGS2—atherosclerosis	5.58e-05	0.0119	CrCbGaD
Mefenamic acid—Diclofenac—ALB—atherosclerosis	5.08e-05	0.0108	CrCbGaD
Mefenamic acid—Ketoprofen—PTGS2—atherosclerosis	5.05e-05	0.0108	CrCbGaD
Mefenamic acid—Flurbiprofen—ALB—atherosclerosis	4.97e-05	0.0106	CrCbGaD
Mefenamic acid—Ketoprofen—ALB—atherosclerosis	4.5e-05	0.00961	CrCbGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AGT—atherosclerosis	1.09e-05	9.82e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.09e-05	9.8e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LIPC—atherosclerosis	1.09e-05	9.79e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LPA—atherosclerosis	1.09e-05	9.79e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOC3—atherosclerosis	1.08e-05	9.73e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOA4—atherosclerosis	1.08e-05	9.7e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LDLR—atherosclerosis	1.07e-05	9.67e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOE—atherosclerosis	1.07e-05	9.62e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—LEP—atherosclerosis	1.07e-05	9.62e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CAV1—atherosclerosis	1.06e-05	9.53e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP7A1—atherosclerosis	1.06e-05	9.53e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—APOA1—atherosclerosis	1.05e-05	9.51e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—CXCL8—atherosclerosis	1.05e-05	9.5e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—BGN—atherosclerosis	1.05e-05	9.48e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CETP—atherosclerosis	1.05e-05	9.45e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—PTGS2—atherosclerosis	1.04e-05	9.42e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.04e-05	9.41e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOA5—atherosclerosis	1.04e-05	9.38e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NAMPT—atherosclerosis	1.04e-05	9.34e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOC3—atherosclerosis	1.02e-05	9.23e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—ESR1—atherosclerosis	1.02e-05	9.19e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LDLR—atherosclerosis	1.02e-05	9.17e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.01e-05	9.11e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.01e-05	9.08e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—F2—atherosclerosis	1.01e-05	9.08e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—SCARB1—atherosclerosis	1e-05	9.05e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PLA2G1B—atherosclerosis	1e-05	9.03e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—ALB—atherosclerosis	9.99e-06	9.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	9.97e-06	8.99e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.9e-06	8.93e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—HSPA1B—atherosclerosis	9.82e-06	8.86e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.81e-06	8.85e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.79e-06	8.83e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.77e-06	8.81e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CYP27A1—atherosclerosis	9.76e-06	8.81e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALOX5—atherosclerosis	9.67e-06	8.72e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—PIK3CG—atherosclerosis	9.63e-06	8.68e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.61e-06	8.67e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—NOS3—atherosclerosis	9.56e-06	8.62e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MMP9—atherosclerosis	9.53e-06	8.6e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NCF1—atherosclerosis	9.51e-06	8.58e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCG1—atherosclerosis	9.48e-06	8.55e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMGCR—atherosclerosis	9.47e-06	8.54e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—NFKB1—atherosclerosis	9.43e-06	8.5e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.38e-06	8.46e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK8—atherosclerosis	9.27e-06	8.36e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALOX15—atherosclerosis	9.26e-06	8.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	9.26e-06	8.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOA2—atherosclerosis	9.26e-06	8.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	9.26e-06	8.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCG5—atherosclerosis	9.14e-06	8.24e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9.13e-06	8.24e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—INS—atherosclerosis	9.12e-06	8.22e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CCL2—atherosclerosis	8.97e-06	8.09e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CYBA—atherosclerosis	8.94e-06	8.06e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.94e-06	8.06e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—FABP4—atherosclerosis	8.92e-06	8.04e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LCAT—atherosclerosis	8.92e-06	8.04e-05	CbGpPWpGaD
Mefenamic acid—AKR1C2—Metabolism—AKT1—atherosclerosis	8.9e-06	8.02e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LPA—atherosclerosis	8.83e-06	7.96e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IGF1—atherosclerosis	8.82e-06	7.95e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PARP1—atherosclerosis	8.75e-06	7.89e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOA4—atherosclerosis	8.75e-06	7.89e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—PTGS2—atherosclerosis	8.74e-06	7.89e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NAMPT—atherosclerosis	8.68e-06	7.82e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.62e-06	7.78e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LIPC—atherosclerosis	8.62e-06	7.77e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP7A1—atherosclerosis	8.6e-06	7.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOC3—atherosclerosis	8.57e-06	7.73e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—VEGFA—atherosclerosis	8.56e-06	7.72e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—BGN—atherosclerosis	8.55e-06	7.71e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.55e-06	7.71e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LDLR—atherosclerosis	8.52e-06	7.68e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.49e-06	7.66e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—STAT3—atherosclerosis	8.47e-06	7.64e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOA5—atherosclerosis	8.47e-06	7.63e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—IL6—atherosclerosis	8.45e-06	7.62e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ABCA1—atherosclerosis	8.44e-06	7.62e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—SERPINE1—atherosclerosis	8.37e-06	7.55e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CETP—atherosclerosis	8.32e-06	7.5e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.22e-06	7.42e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.19e-06	7.39e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.17e-06	7.36e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	8.15e-06	7.35e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—STAT3—atherosclerosis	8.14e-06	7.34e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—MAPK3—atherosclerosis	8.1e-06	7.3e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.06e-06	7.27e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NOS3—atherosclerosis	7.99e-06	7.21e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.98e-06	7.2e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—SCARB1—atherosclerosis	7.96e-06	7.18e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.96e-06	7.18e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CYP27A1—atherosclerosis	7.95e-06	7.17e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALOX5—atherosclerosis	7.87e-06	7.1e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—TGFB1—atherosclerosis	7.86e-06	7.08e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.82e-06	7.05e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Disease—AKT1—atherosclerosis	7.8e-06	7.03e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—MAPK3—atherosclerosis	7.78e-06	7.02e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.75e-06	6.99e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.63e-06	6.88e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—TGFB1—atherosclerosis	7.55e-06	6.81e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	7.53e-06	6.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALOX15—atherosclerosis	7.53e-06	6.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	7.53e-06	6.79e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOA2—atherosclerosis	7.53e-06	6.79e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMGCR—atherosclerosis	7.52e-06	6.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCG5—atherosclerosis	7.44e-06	6.71e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.43e-06	6.7e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.27e-06	6.56e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—HMOX1—atherosclerosis	7.25e-06	6.53e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LPA—atherosclerosis	7.19e-06	6.48e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—CXCL8—atherosclerosis	7.09e-06	6.4e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NAMPT—atherosclerosis	7.06e-06	6.37e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.02e-06	6.33e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LIPC—atherosclerosis	7.01e-06	6.33e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOC3—atherosclerosis	6.97e-06	6.29e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—BGN—atherosclerosis	6.96e-06	6.28e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOB—atherosclerosis	6.94e-06	6.26e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LDLR—atherosclerosis	6.93e-06	6.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.91e-06	6.23e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOA5—atherosclerosis	6.89e-06	6.21e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CETP—atherosclerosis	6.77e-06	6.1e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GSTM1—atherosclerosis	6.75e-06	6.09e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ABCA1—atherosclerosis	6.7e-06	6.05e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.69e-06	6.04e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	6.63e-06	5.98e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—LPL—atherosclerosis	6.63e-06	5.98e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOB—atherosclerosis	6.58e-06	5.93e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.56e-06	5.91e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Metabolism—AKT1—atherosclerosis	6.53e-06	5.89e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.5e-06	5.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.48e-06	5.85e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—SCARB1—atherosclerosis	6.48e-06	5.84e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—GPX1—atherosclerosis	6.47e-06	5.83e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MMP9—atherosclerosis	6.41e-06	5.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALOX5—atherosclerosis	6.4e-06	5.78e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—NFKB1—atherosclerosis	6.35e-06	5.72e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.31e-06	5.69e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CD36—atherosclerosis	6.3e-06	5.68e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—LPL—atherosclerosis	6.28e-06	5.67e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK8—atherosclerosis	6.24e-06	5.63e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMGCR—atherosclerosis	6.12e-06	5.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PRKCG—atherosclerosis	6.11e-06	5.51e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—MTHFR—atherosclerosis	5.97e-06	5.38e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—IL6—atherosclerosis	5.92e-06	5.34e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.92e-06	5.34e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARA—atherosclerosis	5.85e-06	5.28e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—VEGFA—atherosclerosis	5.76e-06	5.19e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—HMOX1—atherosclerosis	5.75e-06	5.19e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NAMPT—atherosclerosis	5.74e-06	5.18e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.71e-06	5.15e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LIPC—atherosclerosis	5.71e-06	5.15e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—STAT3—atherosclerosis	5.7e-06	5.14e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—IL6—atherosclerosis	5.69e-06	5.13e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOC3—atherosclerosis	5.67e-06	5.12e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AGT—atherosclerosis	5.67e-06	5.11e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MTHFR—atherosclerosis	5.66e-06	5.1e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LDLR—atherosclerosis	5.64e-06	5.09e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOE—atherosclerosis	5.55e-06	5.01e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.52e-06	4.98e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOB—atherosclerosis	5.51e-06	4.97e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CETP—atherosclerosis	5.51e-06	4.97e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—PDGFB—atherosclerosis	5.5e-06	4.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—CAV1—atherosclerosis	5.5e-06	4.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—APOA1—atherosclerosis	5.49e-06	4.95e-05	CbGpPWpGaD
Mefenamic acid—AKR1C1—Signaling Pathways—AKT1—atherosclerosis	5.46e-06	4.93e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ABCA1—atherosclerosis	5.45e-06	4.92e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—MAPK3—atherosclerosis	5.45e-06	4.91e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GSTM1—atherosclerosis	5.36e-06	4.83e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—TGFB1—atherosclerosis	5.29e-06	4.77e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—SCARB1—atherosclerosis	5.27e-06	4.76e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOE—atherosclerosis	5.27e-06	4.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—LPL—atherosclerosis	5.26e-06	4.74e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Disease—AKT1—atherosclerosis	5.25e-06	4.73e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—CAV1—atherosclerosis	5.22e-06	4.7e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—APOA1—atherosclerosis	5.2e-06	4.69e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.14e-06	4.63e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—GPX1—atherosclerosis	5.13e-06	4.63e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PIK3CG—atherosclerosis	5.01e-06	4.52e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CD36—atherosclerosis	5e-06	4.51e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMGCR—atherosclerosis	4.98e-06	4.49e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS2—atherosclerosis	4.91e-06	4.42e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PPARG—atherosclerosis	4.84e-06	4.36e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—INS—atherosclerosis	4.75e-06	4.28e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—MTHFR—atherosclerosis	4.74e-06	4.27e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—HMOX1—atherosclerosis	4.68e-06	4.22e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARA—atherosclerosis	4.65e-06	4.19e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AGT—atherosclerosis	4.5e-06	4.06e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—INS—atherosclerosis	4.5e-06	4.06e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.49e-06	4.05e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOB—atherosclerosis	4.48e-06	4.04e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.44e-06	4e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOE—atherosclerosis	4.41e-06	3.98e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Metabolism—AKT1—atherosclerosis	4.39e-06	3.96e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—CAV1—atherosclerosis	4.37e-06	3.94e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.36e-06	3.93e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—APOA1—atherosclerosis	4.36e-06	3.93e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—ALB—atherosclerosis	4.35e-06	3.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—LPL—atherosclerosis	4.28e-06	3.86e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—GPX1—atherosclerosis	4.18e-06	3.77e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—NOS3—atherosclerosis	4.16e-06	3.75e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—SERPINE1—atherosclerosis	4.13e-06	3.73e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CD36—atherosclerosis	4.07e-06	3.67e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—IL6—atherosclerosis	3.98e-06	3.59e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PIK3CG—atherosclerosis	3.98e-06	3.59e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—NOS3—atherosclerosis	3.94e-06	3.56e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—MTHFR—atherosclerosis	3.85e-06	3.48e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—PPARG—atherosclerosis	3.84e-06	3.46e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.81e-06	3.44e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—PTGS2—atherosclerosis	3.81e-06	3.43e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARA—atherosclerosis	3.78e-06	3.41e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—INS—atherosclerosis	3.77e-06	3.4e-05	CbGpPWpGaD
Mefenamic acid—AKR1C3—Signaling Pathways—AKT1—atherosclerosis	3.67e-06	3.31e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AGT—atherosclerosis	3.66e-06	3.3e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOB—atherosclerosis	3.65e-06	3.29e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOE—atherosclerosis	3.59e-06	3.24e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—CAV1—atherosclerosis	3.55e-06	3.21e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.55e-06	3.2e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—APOA1—atherosclerosis	3.55e-06	3.2e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—LPL—atherosclerosis	3.48e-06	3.14e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—ALB—atherosclerosis	3.45e-06	3.11e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—GPX1—atherosclerosis	3.4e-06	3.07e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CD36—atherosclerosis	3.31e-06	2.99e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—NOS3—atherosclerosis	3.3e-06	2.98e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.24e-06	2.92e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.14e-06	2.83e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PPARG—atherosclerosis	3.13e-06	2.82e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARA—atherosclerosis	3.08e-06	2.78e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—INS—atherosclerosis	3.07e-06	2.76e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AGT—atherosclerosis	2.98e-06	2.69e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOE—atherosclerosis	2.92e-06	2.63e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—CAV1—atherosclerosis	2.89e-06	2.61e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—APOA1—atherosclerosis	2.89e-06	2.6e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—STAT3—atherosclerosis	2.81e-06	2.54e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—ALB—atherosclerosis	2.81e-06	2.53e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—MAPK3—atherosclerosis	2.69e-06	2.42e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—NOS3—atherosclerosis	2.69e-06	2.42e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.64e-06	2.38e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—TGFB1—atherosclerosis	2.61e-06	2.35e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PPARG—atherosclerosis	2.54e-06	2.29e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—INS—atherosclerosis	2.49e-06	2.25e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.46e-06	2.22e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—ALB—atherosclerosis	2.29e-06	2.06e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—NOS3—atherosclerosis	2.19e-06	1.97e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—PTGS2—atherosclerosis	2e-06	1.8e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—IL6—atherosclerosis	1.97e-06	1.77e-05	CbGpPWpGaD
Mefenamic acid—PTGS1—Metabolism—AKT1—atherosclerosis	1.91e-06	1.73e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Disease—AKT1—atherosclerosis	1.81e-06	1.64e-05	CbGpPWpGaD
Mefenamic acid—PTGS2—Metabolism—AKT1—atherosclerosis	1.52e-06	1.37e-05	CbGpPWpGaD
Mefenamic acid—CYP2C8—Metabolism—AKT1—atherosclerosis	1.24e-06	1.11e-05	CbGpPWpGaD
Mefenamic acid—CYP2C9—Metabolism—AKT1—atherosclerosis	1.01e-06	9.07e-06	CbGpPWpGaD
